The Questex publications, which include Fierce Pharma, Fierce Biotech, Fierce Healthcare, and Fierce CRO, have agreed to be sold to the Apollo Funds in a deal worth $1.5 billion.
Apollo is acquiring Emerald Holding Inc. and Questex LLC with the intention to combine the businesses into an experiential events and media platform.
“We are excited to partner with Apollo and combine with Emerald to accelerate and scale our business model,” said Questex CEO Paul Miller in a statement. “Questex has built a differentiated experiential platform centered on year-round engagement and high-value customer communities, and we believe this combination creates a compelling opportunity to drive growth through innovation, digital integration, and strategic initiatives.”
Questex’s publications also include Fierce Network (merging Fierce Wireless, Fierce Telecom, and Silverlinings), Fierce Electronics, and Live Design.
Read more about the deal here.
